Active, not recruitingNot applicableNCT03943680

Plasma Rich in Growth Factors in Post-extraction Sockets

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidad de Granada
Principal Investigator
Pablo Galindo-Moreno, DDS, PhD
Universidad de Granada
Intervention
PRGF(device)
Enrollment
30 target
Eligibility
18-75 years · All sexes
Timeline
20192025

Study locations (1)

Collaborators

BTI Biotechnology Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03943680 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials